Tamba, M., Chin, K., Osumi, H., Ogura, M., Fukuoka, S., Udagawa, S., . . . Ooki, A. Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma. Elsevier.
Chicago Style (17th ed.) CitationTamba, M., et al. Real-world Clinical Impact of First-line Immune Checkpoint Inhibitor-based Therapy in Advanced Esophageal Squamous Cell Carcinoma. Elsevier.
MLA (9th ed.) CitationTamba, M., et al. Real-world Clinical Impact of First-line Immune Checkpoint Inhibitor-based Therapy in Advanced Esophageal Squamous Cell Carcinoma. Elsevier.
Warning: These citations may not always be 100% accurate.